Cargando…
Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088342/ https://www.ncbi.nlm.nih.gov/pubmed/30116594 http://dx.doi.org/10.1136/esmoopen-2018-000421 |
| _version_ | 1783346817545535488 |
|---|---|
| author | Pirker, Robert |
| author_facet | Pirker, Robert |
| author_sort | Pirker, Robert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6088342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60883422018-08-16 Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? Pirker, Robert ESMO Open Editorial BMJ Publishing Group 2018-08-10 /pmc/articles/PMC6088342/ /pubmed/30116594 http://dx.doi.org/10.1136/esmoopen-2018-000421 Text en © Author (s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Editorial Pirker, Robert Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| title | Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| title_full | Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| title_fullStr | Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| title_full_unstemmed | Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| title_short | Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| title_sort | is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088342/ https://www.ncbi.nlm.nih.gov/pubmed/30116594 http://dx.doi.org/10.1136/esmoopen-2018-000421 |
| work_keys_str_mv | AT pirkerrobert issmokinghistorythetrulybestbiomarkerforimmunecheckpointinhibitortreatmentinadvancednonsmallcelllungcancer |